Sarasota, FL10 Active Studies

Erectile Dysfunction Clinical Trials in Sarasota, FL

Find 10 actively recruiting erectile dysfunction clinical trials in Sarasota, FL. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
3,656
Enrolling

Recruiting Erectile Dysfunction Studies in Sarasota

RecruitingSarasota, FLNCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

787 participants
Eli Lilly and Company
View Study Details
RecruitingSarasota, FLNCT07070232

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

This study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immunotherapeutic agents (Part 2) in particip...

550 participants
BioNTech SE
View Study Details
RecruitingSarasota, FLNCT05875168

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors....

470 participants
Daiichi Sankyo
View Study Details
RecruitingSarasota, FLNCT05410145

A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

This is a first-in-human (FIH), multicenter, open-label, dose-escalation, and dose-expansion Phase 1/2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and prel...

442 participants
D3 Bio (Wuxi) Co., Ltd
View Study Details
RecruitingSarasota, FLNCT07197827

A Study of YL242 in Subjects With Advanced Solid Tumors

This is a multicenter, open-label study to evaluate the safety and tolerability of YL242 monotherapy and combination in participants with advanced solid malignant tumors....

424 participants
MediLink Therapeutics (Suzhou) Co., Ltd.
View Study Details
RecruitingSarasota, FLNCT05123482

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents...

370 participants
AstraZeneca
View Study Details
RecruitingSarasota, FLNCT04145622

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

This is a single group study of participants with advanced solid tumors who have not been cured by other treatments. It is the first time the drug will be used in humans, and will be in two parts. Th...

250 participants
Daiichi Sankyo
View Study Details
RecruitingSarasota, FLNCT05405595

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

This is a Phase 1b/2, open-label, dose escalation study to evaluate the safety, tolerability, PK, and immunogenicity of ADG126-pembrolizumab combination regimens in patients with advanced/metastatic s...

152 participants
Adagene Inc
View Study Details
RecruitingSarasota, FLNCT06028074

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety, tolerability, pharmacokinetics and clini...

111 participants
Georgiamune Inc
View Study Details
RecruitingSarasota, FLNCT06399757

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors with particular focus o...

100 participants
Apollo Therapeutics Ltd
View Study Details

About Erectile Dysfunction Clinical Trials in Sarasota

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 10 erectile dysfunction clinical trials recruiting participants in Sarasota, FL. These studies are seeking a combined 3,656 participants. Research is being sponsored by Eli Lilly and Company, BioNTech SE, Daiichi Sankyo and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Sarasota — FAQ

Are there erectile dysfunction clinical trials in Sarasota?

Yes, there are 10 erectile dysfunction clinical trials currently recruiting in Sarasota, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sarasota?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sarasota research site will contact you about next steps.

Are clinical trials in Sarasota free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sarasota studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 10 active trials in Sarasota are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated March 2, 2026 from ClinicalTrials.gov